LISA WOLFFE: Open Payments
NPI 1790345981 · JEFFERSONVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,272 in 187 payments from 15 companies in 2025. Trend: 2023 $1,814 · 2024 $1,888 · 2025 $3,272
Food & beverage: $3,049Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $676 |
| Otsuka America Pharmaceutical, Inc. | 30 | $553 |
| E.R. Squibb & Sons, L.L.C. | 18 | $382 |
| ABBVIE INC. | 30 | $311 |
| Alkermes, Inc. | 21 | $297 |
| Neurocrine BioSciences, Inc. | 17 | $231 |
| Axsome Therapeutics, Inc. | 7 | $201 |
| Vanda Pharmaceuticals Inc. | 11 | $182 |
| Lundbeck LLC | 10 | $166 |
| Supernus Pharmaceuticals, Inc. | 5 | $93 |
Products named: REXULTI, VRAYLAR, ARISTADA, UZEDY, INGREZZA, COBENFY, ABILIFY ASIMTUFII, Auvelity.
Industry payments across OH — which companies pay providers there.
